HRCT-proven leflunomide pneumonitis in a patient with psoriatic arthritis and normal lung function tests and chest radiography

Authors:

Abstract
Sir, LEF is a DMARD utilized in the treatment of inflammatory arthritides such as RA and PsA. We note with interest the findings of a recent study published by Sawada et al. [1] concluding that pre-existing interstitial lung disease (ILD) and cigarette smoking are important risk factors for the development of LEF-induced ILD in Japanese patients with RA. There have been several other case reports and case series describing acute interstitial pneumonitis complicating LEF therapy for RA in Japanese populations. However, this complication appears to be extremely rare in the West [2, 3]. We present an unusual case of LEF-induced acute interstitial pneumonitis in a Caucasian patient with PsA with no history of ILD or cigarette smoking.